DIO Eyes Resumption of Implant Business in Iran Amid Hopes for Sanctions Easing... Sales Recovery Expected

DIO, a company specializing in dental implants, is closely watching the potential easing of sanctions resulting from improved relations between the United States and Iran, raising expectations for the normalization of its previously suspended business operations in Iran.

On the 16th, DIO announced that, as the United States and Iran have recently reached common ground, the likelihood of easing sanctions and unfreezing Iranian funds has increased. As a result, the company expects to resume its local implant business in Iran and improve its performance.

The Iranian market was once a key overseas business hub for DIO. Before the sanctions, DIO held around a 30% market share in the Iranian dental implant market, ranking first in the local market.

At that time, the scale of annual exports of dental implants to Iran reached between 15 billion and 20 billion won, accounting for over 20% of DIO's total sales. The company explained that Iran was not only a major market driving global export expansion but also a significant growth engine.

However, as U.S. sanctions against Iran intensified, uncertainty regarding the recovery of local payments increased, and DIO suspended exports of products to Iran. In addition, due to the prolonged impact of sanctions, the collection of accounts receivable became challenging, leading the company to set aside provisions for bad debt and write off uncollectible receivables.

The company expects that, if the progress in negotiations between the United States and Iran leads to actual easing of sanctions and the unfreezing of Iranian funds, its business in Iran will return to normal. Once the frozen funds are released, the risk of payment recovery will be resolved, enabling the resumption of exports and normalization of local operations.

DIO anticipates that, if business in Iran is normalized, it could generate approximately 6 billion won in additional sales this year compared to its existing business plan. Furthermore, from next year, it expects to see an annual increase in sales to Iran of over 10 billion won.

Financial improvements are also expected. A company representative stated that the company could recover about 10 billion won in outstanding receivables, and if provisions for bad debt and previously written-off amounts are reversed, it would have a positive impact on operating profit and cash flow.

A DIO official said, "Normalization of our business in Iran is significant not only for expanding overseas sales but also for improving our financial structure. Based on the recovery of the Iranian market, we expect to expand our business into neighboring Middle Eastern countries such as the United Arab Emirates (UAE), Egypt, Saudi Arabia, and Iraq."

As the possibility of DIO re-entering the Iranian market increases, the business foundations it built in the Middle East are expected to once again emerge as a growth engine for overseas expansion.

This content was produced with the assistance of AI translation services.